01367nas a2200277   4500000000100000008004100001260001300042653000900055653003000064653002500094653001100119653001800130653000900148653002000157653003400177653001700211100001800228700001300246700001200259700001300271245005700284300001100341490000700352520071600359022001401075       2012                            d  c2012 Nov10aAged10aAntimony Sodium Gluconate10aAntiprotozoal Agents10aHumans10aLeishmaniasis10aMale10aMucous Membrane10aOtorhinolaryngologic Diseases10aSaudi Arabia1 aAl-Qahtani MS1 aMalik NW1 aJamil S1 aMekki TE00aDiagnostic dilemma of primary mucosal leishmaniasis.  a1234-80 v333 a<p>Leishmaniasis is caused by Leishmania protozoa. It is widely present in more than 88 countries worldwide, resulting in up to 80,000 deaths annually. Leishmaniasis occurs as visceral, cutaneous, or mucocutaneous variants. Mucosal involvement can occur secondarily to the cutaneous or visceral varieties. However, primary mucosal leishmaniasis (PML) occurs without any present or past cutaneous and or visceral disease. It is extremely rare, and its diagnosis may present a serious challenge. It may be difficult to differentiate it from granulomatous conditions like tuberculosis, sarcoidosis, leprosy, fungal infections, Wegener's granuloma, and neoplasms. Here, we present a case of PML in Saudi Arabia.</p>  a0379-5284